Evidence map›Paper›PMID 41817833›Full record

Observational studyDigestive diseases and sciences2026

Advancing Predictive Modeling of Inflammatory Bowel Disease (IBD) Flares: A Data-Driven Approach Using Lifestyle and Psychosocial Factors from a Remote Monitoring Platform.

Y Okegunna, M Sekar, G M C Adriaans, M J J Cloots, J Zhang, Arta Aliu, E M B Hendrix, M Romberg-Camps, A Rezazadeh Ardabili, Z Mujagic and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Y OkegunnaDepartment of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands. yomi.okegunna@maastrichtuniversity.nl.
M SekarDepartment of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
G M C AdriaansInstitute for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
M J J ClootsDepartment of Gastroenterology-Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
J ZhangDepartment of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Arta AliuDepartment of Gastroenterology-Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
E M B HendrixDepartment of Gastroenterology-Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
M Romberg-CampsDepartment of Gastroenterology and Hepatology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
A Rezazadeh ArdabiliInstitute for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
Z MujagicDepartment of Gastroenterology-Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
A DekkerDepartment of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
M J Pierik *Department of Gastroenterology-Hepatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Rianne R R Fijten *Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Funding

Takeda Netherlands IISR-2019-102915
6 · The paper itself

Abstract

backgroundRecurrent flares are associated with disease progression and have a pronounced impact on the quality of life of people with Inflammatory Bowel Disease (IBD). Models using clinical characteristics only moderately predict flares and therefore difficult to implement in clinical practice. With the rise of remote monitoring platforms such as myIBDcoach, which capture besides clinical disease activity, modifiable lifestyle and psychosocial risk factors and patient-reported outcome measures (PROMs), harnessing real-world data may help improve flare prediction. The aim of this study was to develop and compare five predictive models for flares.

methodThe baseline demographic and clinical data and PROMs related to lifestyle and psychosocial factors were collected from the myIBDcoach telemedicine platform from November 2022 to June 2024. Associations between flares, baseline clinical variables alone, and PROMs variable categories from the myIBDcoach platform were estimated using stepwise group-LASSO logistic regression (G-LASSO) model, which was evaluated with performance matrices using accuracy, area under the curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

resultFour hundred and twenty-nine patients from a prospective observational cohort were selected to create the models. The performance of the G-LASSO regression model with baseline variables and myIBDcoach PROMs (psychosocial and lifestyle factors) was better (accuracy: 71%, ROC-AUC: 77%, sensitivity: 59%, specificity: 91%, PPV: 91%, NPV: 59%) than that of the model with baseline data alone (accuracy: 63%, ROC-AUC: 65%, sensitivity: 51%, specificity: 81%, PPV: 81%, NPV: 52%).

conclusionThe inclusion of subjective health and modifiable lifestyle and psychosocial data improved flare prediction in contrast to clinical characteristics alone, which was evidenced in the model performance matrices (accuracy, AUC, sensitivity, specificity, PPV, NPV). In multifactorial disorders such as IBD, lifestyle, and psychological stressors may intensify inflammatory responses, all of which can be controlled by lifestyle choices including diet, exercise, and stress management, for which this model underscores the need.

Indexed as

Inflammatory Bowel DiseasesLife StyleSymptom Flare UpAdultFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresPrediction AlgorithmsPredictive Learning ModelsPredictive Value of TestsProspective StudiesQuality of LifeRemote Patient MonitoringRisk FactorsG-LASSO regressionIBD flaresmyIBDcoachPrecision MedicineRemote monitoring toolTelemedicine

Identifiers

PMID41817833
PMCPMC13500416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.